Jointly sponsored by Fudan University Shanghai Medical College and the Shanghai Key Laboratory of Organ Transplantation, the 2024 Asian Organ Transplantation Symposium (TSS), hosted by Zhongshan Hospital of Fudan University, will be held in Shanghai from November 22 to 24, 2024. Experts in organ transplantation and related disciplines from both domestic and international communities will be invited to deliver lectures and discuss key and challenging issues in the field of organ transplantation. We would like to introduce the members of the Chinese Section of the Conference Committee:
Conference Chairman
Zhu Tongyu, Chief Physician, Professor, Doctoral Supervisor, Member of the National Committee of the Chinese People’s Political Consultative Conference.
He is currently Vice President of Fudan University Shanghai Medical College, Director of the Shanghai Institute of Bacteriophage and Drug Resistance, Director of the Shanghai Key Laboratory of Organ Transplantation, Director of the Shanghai Kidney Transplantation Quality Control Center, and Director of the Fudan University Research Institute. Recipient of Shanghai Leading Talents, Shanghai Outstanding Academic Leader, Shanghai Health System New 100 Plan, and China Hospital Association 2020 Outstanding Hospital President awards. He also serves as Chairman of the Organ Transplantation Branch of the Shanghai Medical Association and Standing Member of the Organ Transplantation Branch of the Chinese Medical Doctor Association. Deputy Editor-in-Chief of Am J Transplant (Chinese Edition), Standing Editorial Board Member of Organ Transplant, Editorial Board Member of Int J Clin Pract and Chinese Journal of Organ Transplantation, and Reviewer for New Engl J Med, Am J Transplant, and other journals. He has long been engaged in clinical and basic research on kidney transplantation, phage therapy for drug-resistant bacterial infections, BK virus activation mechanisms and prevention/treatment strategies, and pathogen diagnosis and treatment. He has led over fifteen major national science and technology projects, including National Natural Science Foundation of China projects and other scientific research initiatives. In recent years, he has focused particularly on the prevention and control of post-transplantation infections. Since 2018, he has led the first domestic clinical trial of phage therapy for multidrug-resistant bacterial infections. He has published nearly 100 SCI papers in journals such as Emerg Microbes Infect, J Infect, EClinicalMedicine, EMBO J, and Med, and has applied for 11 patents, 5 of which have been granted.
Chinese Members of the Conference Committee
Zhang Xiaodong, M.D., Recipient of the State Council Special Allowance
Current Positions: Professor, Chief Physician, and Doctoral Supervisor at the Urology Department of Beijing Chaoyang Hospital, Capital Medical University. Part-time Academic Roles: Member of the Expert Committee on Organ Donation of the Red Cross Society of China, Member of the Kidney Transplantation Group and Standing Committee of the Organ Transplantation Branch of the Chinese Medical Association, Standing Committee Member of the Urology Branch of the Beijing Medical Association, Chairman of the Urology Committee of the Chaoyang District Society for Preventive Medicine, Editorial Board Member of Transplant Proceedings, Editorial Board Member of the Chinese Journal of Transplantation, and Executive Member of the Transplantation Scientific Symposium (TSS). Contributed to monographs, co-editing “CS Huang Surgery” and “Wu Jieping Urology.” Editor-in-Chief of “Clinical Kidney Transplantation” and “Clinical Medicine for Kidney Transplantation.” Translated “Urodynamics,” “Smith’s Urology,” and “Oncological Surgery.” Awards: China Medical Science and Technology First Prize (ranked second), Beijing Medical Science and Technology Third Prize (ranked first). Research Funding: Led 2 National Natural Science Foundation projects and 1 key project under Beijing’s “Sailing Plan.”
Wan Jun, Chair Professor, Department of Surgery, University of Hong Kong; Director of the Clinical and Translational Laboratory, Laboratory of Liver Transplantation and Liver Cancer, Laboratory of Organ Transplantation and Regeneration, and Central Laboratory at Shenzhen Hospital, University of Hong Kong. Chairman of the Hong Kong Association for Science and Technology (since 2018), Chairman of the Society of Immunology of Hong Kong (since 2023), President of the International Society for Liver Transplantation (2018-2019). Deputy Editor of Transplantation (since 2015). Editorial Board Member of Annals of Surgery (since 2018). Engages in clinical, translational, and basic research on liver transplantation injury, hepatocellular carcinoma, and tumor recurrence post-liver transplantation. His research is at the forefront internationally, with over 200 papers published in renowned journals; his recent innovations have earned the Gold Award at the 2024 Geneva Invention Fair and the Special Award from the China Invention Association.
Fu Yingxin, Director of the Kidney Transplantation Department at Shenzhen No. 3 People’s Hospital, Head of the Organ Transplantation Research Institute. Completed postdoctoral training at Johns Hopkins University, USA, and Professor at Southern University of Science and Technology of China. Has performed over 1,000 kidney transplantations and 80 simultaneous pancreas-kidney transplantations, with follow-up care for over 800 kidney and pancreas transplantation cases. Member of the Pancreas and Small Bowel Transplantation Group, Ninth Committee of the Organ Transplantation Society, Chinese Medical Association. Standing Committee Member, Transplantation Technology Branch, China Medical Biotechnology Association. Standing Committee Member, Kidney Transplantation Branch, China Society for Promotion of International Exchange in Medical Care. Member of the Transplant Medicine Committee, Chinese Research Hospital Association. Member of the International Society for Pancreas and Islet Transplantation. Editorial Board Member of Chinese Journal of Organ Transplantation and other organ transplantation journals. Scientific Achievements: Led 2 National Natural Science Foundation of China projects and 2 Tianjin Health and Family Planning Commission projects; edited 1 organ transplantation follow-up guide and 1 clinical diagnosis and treatment guide for simultaneous pancreas-kidney transplantation; published over 50 SCI and Chinese core papers.
Pang Li, Assistant Researcher at National Sun Yat-sen University, Sun Yat-sen Memorial Hospital, Liver Transplant Center & Department of Biliary and Pancreatic Surgery. Member of the Basic & Translational Research Committee, International Liver Transplantation Society (ILTS). Member of the Youth Committee, Working Group on Accelerated Rehabilitation Surgery (ERAS), International Liver Transplantation Society. Member, Organ Medicine and Technology Society of Guangdong Province. Member of the Immunological Society of Hong Kong (HKSI). Member of the International Transplantation Society (TTS). Member of the International Liver Transplantation Society (ILTS). Member of the Hong Kong Association of Scientific Researchers (HKSA). Research Focus: Immunological mechanisms of hepatocellular carcinoma recurrence after liver transplantation. Graduated from the Department of Surgery, University of Hong Kong in 2021; awarded the “Rising Star Award” and “Vanguard Basic Science Award” by the International Liver Transplantation Society (ILTS). Led one National Cancer Research Foundation project and two special grants from the National Postdoctoral Program; published 6 SCI papers as first author in Cancer Letters and 38 as co-author in Annals of Surgery, Nano Research, and Transplantation.
Lau Kong, Research Assistant Professor, Department of Surgery, University of Hong Kong. Engages in clinical, basic, and translational research in hepatobiliary and pancreatic surgery and liver transplantation, focusing on immunological and metabolic mechanisms and medical applications of biomaterials. Has published 34 SCI papers, with 622 total citations and an H-index of 14. Co-authored international guidelines on biomarkers for accelerated recovery after liver transplantation and a consensus on diagnosing small liver syndrome in living donor liver transplantation. In 2022, identified mild graft steatosis as a risk factor for long-term poor prognosis after living donor liver transplantation. Conducted the first preclinical study of micro-robot-based stem cell therapy for liver cancer. Proposed a theory of the regional immune microenvironment for hepatocellular carcinoma recurrence after liver transplantation. Member of the Youth Committee of the International Society for Liver Transplantation, Scientific Committee of the International Registry of Living Donor Liver Transplantation, Working Group of the World Hilar Cholangiocarcinoma Guidelines, and Youth Committee of the Hong Kong Association of Scientists. Recipient of several international academic awards, including the International Society for Liver Transplantation Outstanding Young Researcher Award, International Society for Transplantation Student-Mentor Award, International Digestive Disease Forum Young Researcher Award, Gold Award at the Geneva International Invention Fair, and Special Commendation Award from the China Invention Association.
Conference Secretary and Contact Person
Yang Cheng
Doctor, Associate Chief Physician, Master’s Supervisor, H-index 26. Member of the Ninth Youth Group and Transplantation Foundation Group, Organ Transplantation Branch, Chinese Medical Association. Member, Immunotherapy Engineering Branch, Chinese Biomedical Engineering Society. Vice Chairman, Transplant Immunology Committee, Immunotherapy Engineering Branch, Chinese Biomedical Engineering Society. Committee Member, Transplantation Technology Branch, China Medical Biotechnology Association. Member of the Youth Committee, Organ Transplantation Branch, Shanghai Medical Association. Currently an Editorial Board Member of Frontiers in Cell and Developmental Biology (IF: 6.081), Young Editorial Board Member of the Chinese Journal of Organ Transplantation, and former Editorial Board Member of the Journal of Translational Medicine (IF: 8.44). Participant in the Shanghai Science and Technology Youth Startup Program. Participant in the Shanghai Top-Notch Young Talents Development Program. Participant in the New Excellent Youth Program of the Shanghai Health System. Participant in the Fudan University Excellence 2025 Program and the China Organ Transplantation Development Foundation Elite Program. Recognized at the 4th Grand Ceremony of Famous Doctors of China – Young Talents. Recipient of 7 Young Scientist/Basic Science Awards from the American Transplant Society, International Transplant Society, and European Transplant Society. As first or corresponding author, published 63 SCI papers with a cumulative impact factor >320 and over 2,000 citations. Expert reviewer for dissertations of the Ministry of Education and the National Natural Science Foundation.
